Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Odin

Showing results (141-150 of 170) with videos related to

Pageof 17
Sort By:
Movement Disorders Clinical Practice|February 13, 2019
Relationship of Nocturnal Sleep Dysfunction and Pain Subtypes in Parkinson's DiseasePablo Martinez-Martin, Alexandra M Rizos, John B Wetmore, et al.
Journal of Parkinson'S Disease|July 4, 2017
A Consensus Set of Outcomes for Parkinson's Disease from the International Consortium for Health Outcomes MeasurementPaul de Roos, Bastiaan R Bloem, Thomas A Kelley, et al.
Journal of Personalized Medicine|August 27, 2021
Personalised Advanced Therapies in Parkinson's Disease: The Role of Non-Motor Symptoms ProfileValentina Leta, Haidar S Dafsari, Anna Sauerbier, et al.
Frontiers in Neurology|June 12, 2023
Chaudhuri's Dashboard of Vitals in Parkinson's syndrome: an unmet need underpinned by real life clinical testsMubasher A Qamar, Silvia Rota, Lucia Batzu, et al.
The Lancet. Neurology|June 3, 2008
Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trialClaudia Trenkwalder, Heike Benes, Werner Poewe, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 4, 2010
The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: an international study using the nonmotor symptoms questionnaireK Ray Chaudhuri, Cristina Prieto-Jurcynska, Yogini Naidu, et al.
The Lancet. Neurology|December 24, 2013
Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy studyC Warren Olanow, Karl Kieburtz, Per Odin, et al.
Movement Disorders Clinical Practice|July 7, 2020
The Prevalence and Determinants of Neuropsychiatric Symptoms in Late-Stage ParkinsonismAdrianus L A J Hommel, Marjan J Meinders, Stefan Lorenzl, et al.
Parkinsonism & Related Disorders|October 25, 2021
Validation and clinical value of the MANAGE-PD tool: A clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medicationsAngelo Antonini, Per Odin, Peter Schmidt, et al.
Journal of Parkinson'S Disease|June 23, 2020
Optimizing Treatment in Undertreated Late-Stage Parkinsonism: A Pragmatic Randomized TrialAdrianus L A J Hommel, Marjan J Meinders, Nico J Weerkamp, et al.
Pageof 17

Showing results (141-150 of 170) with videos related to

Sort By:
Pageof 17
Movement Disorders Clinical Practice|February 13, 2019
Relationship of Nocturnal Sleep Dysfunction and Pain Subtypes in Parkinson's DiseasePablo Martinez-Martin, Alexandra M Rizos, John B Wetmore, et al.
Journal of Parkinson'S Disease|July 4, 2017
A Consensus Set of Outcomes for Parkinson's Disease from the International Consortium for Health Outcomes MeasurementPaul de Roos, Bastiaan R Bloem, Thomas A Kelley, et al.
Journal of Personalized Medicine|August 27, 2021
Personalised Advanced Therapies in Parkinson's Disease: The Role of Non-Motor Symptoms ProfileValentina Leta, Haidar S Dafsari, Anna Sauerbier, et al.
Frontiers in Neurology|June 12, 2023
Chaudhuri's Dashboard of Vitals in Parkinson's syndrome: an unmet need underpinned by real life clinical testsMubasher A Qamar, Silvia Rota, Lucia Batzu, et al.
The Lancet. Neurology|June 3, 2008
Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trialClaudia Trenkwalder, Heike Benes, Werner Poewe, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 4, 2010
The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: an international study using the nonmotor symptoms questionnaireK Ray Chaudhuri, Cristina Prieto-Jurcynska, Yogini Naidu, et al.
The Lancet. Neurology|December 24, 2013
Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy studyC Warren Olanow, Karl Kieburtz, Per Odin, et al.
Movement Disorders Clinical Practice|July 7, 2020
The Prevalence and Determinants of Neuropsychiatric Symptoms in Late-Stage ParkinsonismAdrianus L A J Hommel, Marjan J Meinders, Stefan Lorenzl, et al.
Parkinsonism & Related Disorders|October 25, 2021
Validation and clinical value of the MANAGE-PD tool: A clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medicationsAngelo Antonini, Per Odin, Peter Schmidt, et al.
Journal of Parkinson'S Disease|June 23, 2020
Optimizing Treatment in Undertreated Late-Stage Parkinsonism: A Pragmatic Randomized TrialAdrianus L A J Hommel, Marjan J Meinders, Nico J Weerkamp, et al.
Pageof 17